
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion.image/iStock
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion
Sanstar Ltd has submitted its draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) in anticipation of an upcoming initial public offering (IPO). This Ahmedabad-based enterprise specializes in producing plant-based specialty products and ingredient solutions utilized across various industrial, animal nutrition, and food applications within India.
In this exciting development, Sanstar Limited’s IPO encompasses an offer for sale (OFS) by selling shareholders, involving up to 8 million shares, and a fresh issue of up to 40 million shares. The company may also consider a pre-IPO placement of up to 4 million shares, contingent upon discussions with the Book Running Lead Manager (BRLM). The face value of a company share is ₹2.
The proposed utilization of fresh issue proceeds includes funding part of the capital expenditure required for expanding the Dhule facility, amounting to approximately ₹182 crores. Additionally, the remaining net proceeds, up to ₹100 crores, are earmarked for specific borrowing repayment and/or prepayment. Any net proceeds beyond expenses will be directed towards general corporate needs and issue costs.
In the fiscal year 2023, the company reported consolidated revenue of approximately ₹1,180 crores, with an EBITDA of about ₹73 crores and a Profit After Tax (PAT) of roughly ₹42 crores. The company’s Return on Equity (ROE) and Return on Capital Employed (ROCE) stood at approximately 28% and 24%, respectively. On a stand-alone basis, revenue, EBITDA, and PAT demonstrated a Compound Annual Growth Rate (CAGR) of around 57%, 39%, and 71%, respectively, between FY21 and FY23.
Sanstar boasts a global presence, exporting its products to over 45 nations across the Middle East, Africa, Asia, Americas, Europe, and Oceania. Notably, more than 30% of the company’s total revenue is derived from exports. The company’s Kutch facility holds registration with the US Food and Drug Administration (USFDA), underlining its commitment to quality standards.
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion:In case of rectification of any error in article , Visit on Correction Policy & Register your Query:
Latest Posts
- Speeding Tempo Collides Head-On With Ambulance On Yamuna Expressway, 2 Dead
August 5, 2026 | Breaking News, India - Pakistan beats West Indies to end 8-match overseas losing streak in test matches
August 5, 2026 | Breaking News, Sports - Dangote Refinery May List on South Africa’s Johannesburg Stock Exchange After Nigeria IPO
August 5, 2026 | Breaking News, Business, Stock Market - Ukrainian President Volodymyr Zelenskiy, NATO Chief Mark Rutte Discuss Securing More Air Defence Missiles for Ukraine
August 5, 2026 | Breaking News, Politics, World - Major Wall Street hedge funds targeted in attempted cyberattacks, Bloomberg News reports
August 5, 2026 | Breaking News, Business, Stock Market - Activist investor Starboard takes new position in Shake Shack, Bloomberg News reports
August 5, 2026 | Breaking News, Business, Stock Market - Italy’s Banco BPM Quarterly Results Boosts After Strong Quarterly Performance
August 5, 2026 | Breaking News, Business, Stock Market - SpaceX Shares Gain Retail Support Following Sharp Post-Earnings Fall
August 5, 2026 | Breaking News, Business, Markets - Iran and Oman Reach Deal on Strait of Hormuz Maritime Route
August 5, 2026 | Breaking News, Politics, World - Sheikh Hasina Pledges Return to Bangladesh, Says ‘I Will Go Back Home’
August 5, 2026 | Breaking News, Politics, World